- Home
- GLMD vs FTEL Comparison
GLMD vs FTEL Comparison
Compare GLMD & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- FTEL
- Stock Information
- Founded
- GLMD 2000
- FTEL 2007
- Country
- GLMD Israel
- FTEL Australia
- Employees
- GLMD N/A
- FTEL N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- GLMD Health Care
- FTEL
- Exchange
- GLMD Nasdaq
- FTEL Nasdaq
- Market Cap
- GLMD 8.0M
- FTEL 9.1M
- IPO Year
- GLMD 2014
- FTEL 2023
- Fundamental
- Price
- GLMD $1.42
- FTEL $4.37
- Analyst Decision
- GLMD Hold
- FTEL
- Analyst Count
- GLMD 1
- FTEL 0
- Target Price
- GLMD N/A
- FTEL N/A
- AVG Volume (30 Days)
- GLMD 72.8K
- FTEL 451.6K
- Earning Date
- GLMD 11-13-2025
- FTEL 11-27-2025
- Dividend Yield
- GLMD N/A
- FTEL N/A
- EPS Growth
- GLMD N/A
- FTEL N/A
- EPS
- GLMD N/A
- FTEL N/A
- Revenue
- GLMD N/A
- FTEL $4,990,695.00
- Revenue This Year
- GLMD N/A
- FTEL N/A
- Revenue Next Year
- GLMD N/A
- FTEL N/A
- P/E Ratio
- GLMD N/A
- FTEL N/A
- Revenue Growth
- GLMD N/A
- FTEL 29.02
- 52 Week Low
- GLMD $1.15
- FTEL $3.54
- 52 Week High
- GLMD $4.81
- FTEL $792.00
- Technical
- Relative Strength Index (RSI)
- GLMD 45.67
- FTEL 52.76
- Support Level
- GLMD $1.37
- FTEL $3.98
- Resistance Level
- GLMD $1.50
- FTEL $4.90
- Average True Range (ATR)
- GLMD 0.09
- FTEL 0.62
- MACD
- GLMD -0.01
- FTEL -0.27
- Stochastic Oscillator
- GLMD 23.33
- FTEL 32.30
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.